MMWR
Morbidity and Mortality Weekly Report
MMWR News Synopsis for December 3, 2009
- Idiopathic Granulomatous Mastitis in Hispanic Women – Indiana, 2006-2008
- Global Measles Mortality Reduction and the Risk for Resurgence, 2000-2008
There is no MMWR telebriefing scheduled for December 3, 2009.
1. Idiopathic Granulomatous Mastitis in Hispanic Women – Indiana, 2006-2008
Press Contact: CDC
Division of Media Relations
(404) 636-3286
In the largest cluster of idiopathic granulomatous mastitis (IGM) ever reported in the United States, all affected patients were young Hispanic women who experienced delays in receiving healthcare. Idiopathic granulomatous mastitis (IGM) is a very rare disease with symptoms similar to breast cancer. The cause is unknown. In the largest cluster of IGM ever reported in the United States, seven young Hispanic women in Indiana were diagnosed with IGM during 2006-2009. This is the first time that researchers have found a higher prevalence of IGM in a particular ethnic group (Hispanics) in the United States. All of the patients experienced delays in care, with an average of five months delay between symptom onset and diagnostic biopsy. In a CDC case-control study, significant risk factors were low education levels, positive tuberculin skin test results, and medication allergies. Recognizing barriers to prompt healthcare access might suggest outreach opportunities.
2. Global Measles Mortality Reduction and the Risk for Resurgence, 2000-2008
Press Contact: CDC
Division of Media Relations
(404) 636-3286
While strong progress toward the 90 percent measles mortality reduction goal has been made, achieving the goal depends on (1) India fully implementing the recommended measles mortality reduction strategies, and (2) securing financial support to sustaining measles control in the other 46 high-burden countries. In a global public health success, measles deaths worldwide fell by 78 percent between 2000 and 2008, from an estimated 733 000 to 164 000. However, since 2007, the reduction in measles mortality has begun to level off and funding support to the Measles Initiative for global measles mortality reduction has declined from $150 million annually to approximately $50 million. In addition, India, the country with the most measles deaths, has not yet fully implemented measles mortality reduction strategies. Global immunization experts express concern that the U.N. goal of a 90 percent reduction in measles deaths by 2010 (compared with 2000) might not be achieved and warn of a risk of resurgence in measles deaths if vaccination efforts are not sustained.
####
- Historical Document: December 3, 2009
- Content source: Office of Enterprise Communication
- Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.
View Press Releases in
Get e-mail updates
To receive e-mail updates about this page, enter your
e-mail address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC-INFO